Assay Development, DNA and White Paper

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Assay Development

DNA

White Paper

Listicle: Maximising outsourcing models beyond time and cost

Drug Discovery World

SEPTEMBER 29, 2022

This white paper expands on three key factors – cost, time, and innovation – and illustrates how integrating these factors will minimise the challenges and ensure success in outsourcing drug discovery. Designing DEL libraries has benefited from the development of AI to model compounds based on binding pockets. Conclusion.

Small Molecule

Small Molecule Assay Development DNA Biochemical Assays

Article FDA Thank You The next chapter in the ctDNA story: Still promising, not ready for prime time

Agency IQ

JULY 21, 2023

The next chapter in the ctDNA story: Still promising, not ready for prime time A recent workshop summed up the state of play for circulating tumor DNA. As dying cancer cells degrade, their cell contents are released into the patient’s circulation, affording the possibility of detecting fragments of DNA that are unique to the cancer.

FDA

FDA Clinical Trials DNA Treatment

Drug Discovery Digest

Listicle: Maximising outsourcing models beyond time and cost

Article FDA Thank You The next chapter in the ctDNA story: Still promising, not ready for prime time

Stay Connected